Zoledronic Acidum Monohydrate CAS 165800-06-6 Puritas ≥99.0% API Factory Mundities
Manufacturer cum High puritate et stabulo Quality
Chemical Name: Zoledronic Acidum Monohydrate
CAS: 165800-06-6
Plurimum potentem bisphosphonatum et activator PKC
API High Quality, Commercial Production
Nomen chemicum | Zoledronic Acidum Monohydrate |
CAS Number | 165800-06-6 |
CATTUS Number | RF-API56 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C5H12N2O8P2 |
M. Pondus | 290.1 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba vel prope Crystallina pulveris |
Lepidium sativum | IR Imaginum;HPLC ChromatogramUV-Vis: Est maximus absorbance ad 210nm |
pH | 2.0~4.0 |
Solubilitas | Parce solutum in 0.1N solutione sodii hydroxidi, in aqua leviter solubili et 0.1N acido hydrochlorico, in ethanolo fere insolubili. |
Claritas et Color | Solutio debet esse pura et hyalina;si opalescent, non magis opalescent quam suspensio 1 referentia;si colorata non intentius colorata quam Y2 |
una immunditia | ≤0.50% |
Totalis immunditias | ≤1.0% |
Damnum in Siccatio | 5.0%~8.0% |
Chloride | ≤0.04% |
Phosphate | ≤0.50% |
Phosphite | ≤0.50% |
Metalla gravis | ≤10ppm |
Puritas | ≥99.0% |
Test Standard | Enterprise Standard |
Consuetudinem | API |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Monohydratorum acidum zoledronicum valde potentem bisphosphonatum et activatorem PKC.Zoledronici monohydratorum acidum heterocyclicum bisphosphonatum est, quod summam vim bisphosphonatorum ad suppressionem ossis resorptionis auctae habere censetur et in pluribus osteoporosis studiis adhibitus est.Monohydratorum acidum zoledronicum inhibitor est ASM et FDPS et activator PKC.Acidum zoledronicum (zoledronatum) est ossis bisphosphonatis inhibitor resorptionis, inhibitor diphosphatae farnesylis (FPP) synthasis quae consequitur in amni inhibitionis osteoclastis activitatis et ossis resorptionis et materia prima.Usus est postmenopausalem osteoporosis, morbum Paget, hypercalcemiam, et cum chemotherapyre cancro tractare, damnum ossis a cancro ad ossa dissectum tractare adhibitum est.